Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients
Laura S. Mertens, Francesco Claps, Roman Mayr, Peter J. Boström, Shahrokh F. Shariat, Ellen C. Zwarthoff, Joost L. Boormans, Cheno Abas, Geert J.L.H. van Leenders, S. A. Gotz, Katrin Hippe, Simone Bertz, Y. Neuzillet, Joyce Sanders, Annegien Broeks, Dennis Peters, Michiel S. van der Heijden, Michael A.S. Jewett, Robert Stöhr, Alexandre R. Zlotta, Markus Eckstein, Yanish Soorojebally, Deric K. E. van der Schoot, Bernd Wullich, Maximilian Burger, Wolfgang Otto, François Radvanyi, Nanour Sirab, Damien Pouessel, Theodorus van der Kwast, Arndt Hartmann, Yair Lotan, Yves Allory, Tahlita C.M. Zuiverloon, Bas W.G. van Rhijn
Topics & Concepts
CystectomyMedicineBladder cancerImmunohistochemistryStage (stratigraphy)Lymph nodeInternal medicineKi-67GastroenterologySingle CenterOncologyPathologyCancerUrologyBiologyPaleontologyBladder and Urothelial Cancer TreatmentsFibroblast Growth Factor ResearchUrinary and Genital Oncology Studies